Neural network based glucose - insulin metabolism models for children with Type 1 diabetes

Stavroula G Mougiakakou1, Aikaterini Prountzou, Dimitra Iliopoulou

  • 1Fac. of Electr. & Comput. Eng., Nat. Tech. Univ. of Athens, Zographou, Greece. smougia@cc.ece.ntua.gr

Insights

This study presents hybrid models combining compartmental models and artificial neural networks for simulating glucose-insulin metabolism in children with Type 1 diabetes. Recurrent Neural Networks (RNNs) demonstrated superior short-term glucose prediction performance.

Area of Science:

  • Biomedical Engineering
  • Computational Biology
  • Endocrinology

Background:

  • Type 1 diabetes management requires accurate glucose level prediction.
  • Simulating glucose-insulin metabolism is crucial for developing effective treatment strategies.
  • Existing models may not fully capture the complex dynamics of pediatric Type 1 diabetes.

Purpose of the Study:

  • To develop and evaluate hybrid computational models for simulating glucose-insulin metabolism in children with Type 1 diabetes.
  • To compare the predictive performance of different artificial neural network architectures for short-term glucose forecasting.
  • To integrate compartmental models with neural networks for enhanced metabolic simulation.

Main Methods:

  • Development of two hybrid models combining Compartmental Models (CMs) and artificial Neural Networks (NNs).
  • Utilized data from four children with Type 1 diabetes, including continuous glucose monitoring, insulin, and food intake.
  • Compared Feed-Forward Neural Networks (FFNNs) and Recurrent Neural Networks (RNNs) for glucose prediction.

Main Results:

  • CMs successfully estimated the influence of insulin on plasma insulin and food intake on blood glucose.
  • The hybrid models provided short-term predictions of glucose values.
  • Recurrent Neural Networks (RNNs) achieved the best prediction performance compared to FFNNs.

Conclusions:

  • Hybrid models integrating CMs and NNs are effective for simulating glucose-insulin metabolism in pediatric Type 1 diabetes.
  • RNNs offer superior accuracy for short-term glucose level prediction in this population.
  • These models hold promise for improving diabetes management tools.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...